AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
BLOCKADE OF GLUTAMATERGIC TRANSMISSION AS TREATMENT FOR DYSKINESIAS AND MOTOR FLUCTUATIONS IN PARKINSONS-DISEASE
Authors: METMAN LV DELDOTTO P BLANCHET PJ VANDENMUNCKHOF P CHASE TN
Citation: Lv. Metman et al., BLOCKADE OF GLUTAMATERGIC TRANSMISSION AS TREATMENT FOR DYSKINESIAS AND MOTOR FLUCTUATIONS IN PARKINSONS-DISEASE, Amino acids, 14(1-3), 1998, pp. 75-82
AMANTADINE REDUCES LEVODOPA-INDUCED DYSKINESIAS IN PARKINSONIAN MONKEYS
Authors: BLANCHET PJ KONITSIOTIS S CHASE TN
Citation: Pj. Blanchet et al., AMANTADINE REDUCES LEVODOPA-INDUCED DYSKINESIAS IN PARKINSONIAN MONKEYS, Movement disorders, 13(5), 1998, pp. 798-802
A TRIAL OF DEXTROMETHORPHAN IN PARKINSONIAN-PATIENTS WITH MOTOR RESPONSE COMPLICATIONS
Authors: METMAN LV BLANCHET PJ VANDENMUNCKHOF P DELDOTTO P NATTE R CHASE TN
Citation: Lv. Metman et al., A TRIAL OF DEXTROMETHORPHAN IN PARKINSONIAN-PATIENTS WITH MOTOR RESPONSE COMPLICATIONS, Movement disorders, 13(3), 1998, pp. 414-417
OPPOSITE ROTATION INDUCED BY DOPAMINE AGONISTS IN RATS WITH UNILATERAL LESIONS OF THE GLOBUS-PALLIDUS OR SUBSTANTIA-NIGRA
Authors: KONITSIOTIS S KAFETZOPOULOS E ANASTASOPOULOS D BLANCHET PJ
Citation: S. Konitsiotis et al., OPPOSITE ROTATION INDUCED BY DOPAMINE AGONISTS IN RATS WITH UNILATERAL LESIONS OF THE GLOBUS-PALLIDUS OR SUBSTANTIA-NIGRA, Behavioural brain research, 92(1), 1998, pp. 77-83
NEOSTRIATAL MECHANISMS IN PARKINSONS-DISEASE
Authors: CHASE TN OH JD BLANCHET PJ
Citation: Tn. Chase et al., NEOSTRIATAL MECHANISMS IN PARKINSONS-DISEASE, Neurology, 51(2), 1998, pp. 30-35
CHRONIC EXPOSURE TO MPTP AS A PRIMATE MODEL OF PROGRESSIVE PARKINSONISM - A PILOT-STUDY WITH A FREE-RADICAL SCAVENGER
Authors: BLANCHET PJ KONITSIOTIS S HYLAND K ARNOLD LA PETTIGREW KD CHASE TN
Citation: Pj. Blanchet et al., CHRONIC EXPOSURE TO MPTP AS A PRIMATE MODEL OF PROGRESSIVE PARKINSONISM - A PILOT-STUDY WITH A FREE-RADICAL SCAVENGER, Experimental neurology, 153(2), 1998, pp. 214-222
CONTINUOUS OR PULSATILE CHRONIC D-2 DOPAMINE-RECEPTOR AGONIST (U91356A) TREATMENT OF DRUG-NAIVE 4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MONKEYSDIFFERENTIALLY REGULATES BRAIN D-1 AND D-2 RECEPTOR EXPRESSION - IN-SITU HYBRIDIZATION HISTOCHEMICAL ANALYSIS
Authors: GOULET M MORISSETTE M CALON F BLANCHET PJ FALARDEAU P BEDARD PJ DIPAOLO T
Citation: M. Goulet et al., CONTINUOUS OR PULSATILE CHRONIC D-2 DOPAMINE-RECEPTOR AGONIST (U91356A) TREATMENT OF DRUG-NAIVE 4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MONKEYSDIFFERENTIALLY REGULATES BRAIN D-1 AND D-2 RECEPTOR EXPRESSION - IN-SITU HYBRIDIZATION HISTOCHEMICAL ANALYSIS, Neuroscience, 79(2), 1997, pp. 497-507
PREPROENKEPHALIN MESSENGER-RNA EXPRESSION IN THE CAUDATE-PUTAMEN OF MPTP MONKEYS AFTER CHRONIC TREATMENT WITH THE D-2 AGONIST U91356A IN CONTINUOUS OR INTERMITTENT MODE OF ADMINISTRATION - COMPARISON WITH L-DOPA THERAPY
Authors: MORISSETTE M GOULET M SOGHOMONIAN JJ BLANCHET PJ CALON F BEDARD PJ DIPAOLO T
Citation: M. Morissette et al., PREPROENKEPHALIN MESSENGER-RNA EXPRESSION IN THE CAUDATE-PUTAMEN OF MPTP MONKEYS AFTER CHRONIC TREATMENT WITH THE D-2 AGONIST U91356A IN CONTINUOUS OR INTERMITTENT MODE OF ADMINISTRATION - COMPARISON WITH L-DOPA THERAPY, Molecular brain research, 49(1-2), 1997, pp. 55-62
MODULATION OF LEVODOPA-INDUCED MOTOR RESPONSE COMPLICATIONS BY NMDA ANTAGONISTS IN PARKINSONS-DISEASE
Authors: BLANCHET PJ PAPA SM METMAN LV MOURADIAN MM CHASE TN
Citation: Pj. Blanchet et al., MODULATION OF LEVODOPA-INDUCED MOTOR RESPONSE COMPLICATIONS BY NMDA ANTAGONISTS IN PARKINSONS-DISEASE, Neuroscience and biobehavioral reviews, 21(4), 1997, pp. 447-453
THE EFFECT OF DEXTROMETHORPHAN ON LEVODOPA ASSOCIATED DYSKINESIAS IN PARKINSONS-DISEASE
Authors: METMAN LV BLANCHET PJ NATTE R MOURADIAN MM CHASE TN
Citation: Lv. Metman et al., THE EFFECT OF DEXTROMETHORPHAN ON LEVODOPA ASSOCIATED DYSKINESIAS IN PARKINSONS-DISEASE, Neurology, 48(3), 1997, pp. 5137-5137
MOTOR RESPONSE TO A DOPAMINE D3 RECEPTOR PREFERRING AGONIST COMPARED TO APOMORPHINE IN LEVODOPA-PRIMED 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MONKEYS
Authors: BLANCHET PJ KONITSIOTIS S CHASE TN
Citation: Pj. Blanchet et al., MOTOR RESPONSE TO A DOPAMINE D3 RECEPTOR PREFERRING AGONIST COMPARED TO APOMORPHINE IN LEVODOPA-PRIMED 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MONKEYS, The Journal of pharmacology and experimental therapeutics, 283(2), 1997, pp. 794-799
ACUTE PHARMACOLOGICAL BLOCKADE OF DYSKINESIAS IN PARKINSONS-DISEASE
Authors: BLANCHET PJ METMAN LV MOURADIAN MM CHASE TN
Citation: Pj. Blanchet et al., ACUTE PHARMACOLOGICAL BLOCKADE OF DYSKINESIAS IN PARKINSONS-DISEASE, Movement disorders, 11(5), 1996, pp. 580-581
EFFECT OF THE PUTATIVE DOPAMINE D-1 AGONIST AND D-2 ANTAGONIST FCE-23884 ON PARKINSONS-DISEASE
Authors: METMAN LV BLANCHET PJ DEJONG D MOURADIAN MM CHASE TN
Citation: Lv. Metman et al., EFFECT OF THE PUTATIVE DOPAMINE D-1 AGONIST AND D-2 ANTAGONIST FCE-23884 ON PARKINSONS-DISEASE, Movement disorders, 11(3), 1996, pp. 257-260
DYSKINESIA AND WEARING-OFF FOLLOWING DOPAMINE D-1 AGONIST TREATMENT IN DRUG-NAIVE ETHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-LESIONED PRIMATES
Authors: BLANCHET PJ GRONDIN R BEDARD PJ
Citation: Pj. Blanchet et al., DYSKINESIA AND WEARING-OFF FOLLOWING DOPAMINE D-1 AGONIST TREATMENT IN DRUG-NAIVE ETHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-LESIONED PRIMATES, Movement disorders, 11(1), 1996, pp. 91-94
PROGRESSIVE CHOREIC AND DYSTONIC DYSKINESIAS INDUCED BY A D1 AGONIST IN NONPRIMED MPTP-TREATED PRIMATES
Authors: PAPA SM BLANCHET PJ CHASE TN
Citation: Sm. Papa et al., PROGRESSIVE CHOREIC AND DYSTONIC DYSKINESIAS INDUCED BY A D1 AGONIST IN NONPRIMED MPTP-TREATED PRIMATES, Annals of neurology, 40(3), 1996, pp. 178-178
RISK-FACTORS FOR PEAK DOSE DYSKINESIA IN 100 LEVODOPA-TREATED PARKINSONIAN-PATIENTS
Authors: BLANCHET PJ ALLARD P GREGOIRE L TARDIF F BEDARD PJ
Citation: Pj. Blanchet et al., RISK-FACTORS FOR PEAK DOSE DYSKINESIA IN 100 LEVODOPA-TREATED PARKINSONIAN-PATIENTS, Canadian journal of neurological sciences, 23(3), 1996, pp. 189-193
L-DOPA REGULATES GLUTAMATE DECARBOXYLASES MESSENGER-RNA LEVELS IN MPTP-TREATED MONKEYS
Authors: SOGHOMONIAN JJ PEDNEAULT S BLANCHET PJ GOULET M DIPAOLO T BEDARD PJ
Citation: Jj. Soghomonian et al., L-DOPA REGULATES GLUTAMATE DECARBOXYLASES MESSENGER-RNA LEVELS IN MPTP-TREATED MONKEYS, Molecular brain research, 39(1-2), 1996, pp. 237-240
CHANGES OF D-1 AND D-2 DOPAMINE-RECEPTOR MESSENGER-RNA IN THE BRAINS OF MONKEYS LESIONED WITH 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE - CORRECTION WITH CHRONIC ADMINISTRATION OF L-3,4-DIHYDROXYPHENYLALANINE
Authors: MORISSETTE M GOULET M CALON F FALARDEAU P BLANCHET PJ BEDARD PJ DIPAOLO T
Citation: M. Morissette et al., CHANGES OF D-1 AND D-2 DOPAMINE-RECEPTOR MESSENGER-RNA IN THE BRAINS OF MONKEYS LESIONED WITH 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE - CORRECTION WITH CHRONIC ADMINISTRATION OF L-3,4-DIHYDROXYPHENYLALANINE, Molecular pharmacology, 50(5), 1996, pp. 1073-1079
DOPAMINE D-1 RECEPTOR DESENSITIZATION PROFILE IN MPTP-LESIONED PRIMATES
Authors: BLANCHET PJ GRONDIN R BEDARD PJ SHIOSAKI K BRITTON DR
Citation: Pj. Blanchet et al., DOPAMINE D-1 RECEPTOR DESENSITIZATION PROFILE IN MPTP-LESIONED PRIMATES, European journal of pharmacology, 309(1), 1996, pp. 13-20
IS STRIATAL DOPAMINERGIC RECEPTOR IMBALANCE RESPONSIBLE FOR LEVODOPA-INDUCED DYSKINESIA
Authors: BLANCHET PJ GOMEZMANCILLA B DIPAOLO T BEDARD PJ
Citation: Pj. Blanchet et al., IS STRIATAL DOPAMINERGIC RECEPTOR IMBALANCE RESPONSIBLE FOR LEVODOPA-INDUCED DYSKINESIA, Fundamental and clinical pharmacology, 9(5), 1995, pp. 434-442
DOPA-INDUCED PEAK DOSE DYSKINESIA - CLUES IMPLICATING D2 RECEPTOR-MEDIATED MECHANISMS USING DOPAMINERGIC AGONISTS IN MPTP MONKEYS
Authors: BLANCHET PJ GOMEZMANCILLA B BEDARD PJ
Citation: Pj. Blanchet et al., DOPA-INDUCED PEAK DOSE DYSKINESIA - CLUES IMPLICATING D2 RECEPTOR-MEDIATED MECHANISMS USING DOPAMINERGIC AGONISTS IN MPTP MONKEYS, Journal of neural transmission. Supplementum, (45), 1995, pp. 103-112
THE D-1 DOPAMINE-RECEPTOR - PAST, PRESENT AND FUTURE AN IDIOSYNCRATICREVIEW
Authors: KEBABIAN JW BLANCHET PJ BEDARD P
Citation: Jw. Kebabian et al., THE D-1 DOPAMINE-RECEPTOR - PAST, PRESENT AND FUTURE AN IDIOSYNCRATICREVIEW, Progress in neuro-psychopharmacology & biological psychiatry, 19(5), 1995, pp. 757-778
SUPPRESSION OF LEVODOPA-INDUCED DYSKINESIAS BY AN NMDA RECEPTOR ANTAGONIST IN MPTP TREATED MONKEYS
Authors: PAPA SM BLANCHET PJ LINFANTE I CHASE TN
Citation: Sm. Papa et al., SUPPRESSION OF LEVODOPA-INDUCED DYSKINESIAS BY AN NMDA RECEPTOR ANTAGONIST IN MPTP TREATED MONKEYS, Neurology, 45(7), 1995, pp. 1417-1417
CONTINUOUS ADMINISTRATION DECREASES AND PULSATILE ADMINISTRATION INCREASES BEHAVIORAL SENSITIVITY TO A NOVEL DOPAMINE D-2 AGONIST (U-91356A) IN MPTP-EXPOSED MONKEYS
Authors: BLANCHET PJ CALON F MARTEL JC BEDARD PJ DIPAOLO T WALTERS RR PIERCEY MF
Citation: Pj. Blanchet et al., CONTINUOUS ADMINISTRATION DECREASES AND PULSATILE ADMINISTRATION INCREASES BEHAVIORAL SENSITIVITY TO A NOVEL DOPAMINE D-2 AGONIST (U-91356A) IN MPTP-EXPOSED MONKEYS, The Journal of pharmacology and experimental therapeutics, 272(2), 1995, pp. 854-859
LEVODOPA OR D2 AGONIST-INDUCED DYSKINESIA IN MPTP MONKEYS - CORRELATION WITH CHANGES IN DOPAMINE AND GABA(A) RECEPTORS IN THE STRIATOPALLIDAL COMPLEX
Authors: CALON F GOULET M BLANCHET PJ MARTEL JC PIERCEY MF BEDARD PJ DIPAOLO T
Citation: F. Calon et al., LEVODOPA OR D2 AGONIST-INDUCED DYSKINESIA IN MPTP MONKEYS - CORRELATION WITH CHANGES IN DOPAMINE AND GABA(A) RECEPTORS IN THE STRIATOPALLIDAL COMPLEX, Brain research, 680(1-2), 1995, pp. 43-52
Risultati: 1-25 | 26-26